- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Amarin Corporation PLC (AMRN)
Amarin Corporation PLC stock price live, this page displays NASDAQ AMRN stock exchange data. View the AMRN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Amarin Corporation PLC real time stock price chart below.
What Is the Amarin Corporation PLC Stock Price Today?
The Amarin Corporation PLC stock price today is 15.160.
What Is the Stock Symbol for Amarin Corporation PLC?
The stock symbol for Amarin Corporation PLC is ""AMRN.""
What Stock Exchange Does Amarin Corporation PLC Trade On?
Amarin Corporation PLC is listed and trades on the NASDAQ stock exchange.
Is Amarin Corporation PLC a Good Stock to Buy?
Determining whether Amarin Corporation PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AMRN quote. (ISIN: US0231114044)
What Is the Amarin Corporation PLC Stock Price Today?
The Amarin Corporation PLC stock price today is 15.160.
What Is the Stock Symbol for Amarin Corporation PLC?
The stock symbol for Amarin Corporation PLC is ""AMRN.""
What Stock Exchange Does Amarin Corporation PLC Trade On?
Amarin Corporation PLC is listed and trades on the NASDAQ stock exchange.
Is Amarin Corporation PLC a Good Stock to Buy?
Determining whether Amarin Corporation PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AMRN quote. (ISIN: US0231114044)
15.160
+0.640(+4.41%)
Closed·
After Hours
15.090-0.070(-0.46%)
·
Fair Value
An estimate of a Amarin's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.050
15.651
52 wk Range
7.080
17.490
AMRN Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
AMRN is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Amarin's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.05015.651
52 wk Range
7.08017.490
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
AMRN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Amarin's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
11.000
Downside
-27.44%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Amarin Corporation PLC Company Profile
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally through wholesalers, selected regional wholesalers, and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin 2, Ireland.
Amarin Corporation PLC Earnings Call Summary for Q4/2024
- Q4 2024 EPS beats forecast at -0.02 vs -0.05, but revenue falls to $62.3M from $74.7M in Q4 2023; stock drops 6.38% premarket
- U.S. product revenue declines, offset by growth in European and partnership revenue; company maintains $294M cash position with no debt
- Vascepa patent protection in Europe extended to 2039; company focuses on maximizing U.S. revenue efficiency and global market expansion
- CEO emphasizes need for strategies beyond LDL lowering; expects impact from CVS coverage changes in first two quarters of 2025
- Analysts forecast continued sales decline; company maintains "FAIR" financial health score according to InvestingPro metrics
Last Updated: 12/03/2025, 13:58
Read Full TranscriptCompare AMRN to Peers and Sector
Metrics to compare | AMRN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAMRNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.0x | −1.8x | −0.5x | |
PEG Ratio | 0.02 | −0.10 | 0.00 | |
Price/Book | 0.7x | 2.2x | 2.6x | |
Price / LTM Sales | 1.4x | 7.7x | 3.3x | |
Upside (Analyst Target) | −27.4% | 537.2% | 45.1% | |
Fair Value Upside | Unlock | 21.0% | 7.4% | Unlock |
Analyst Ratings
0 Buy
1 Hold
2 Sell
Ratings:
3 analysts
Overall Consensus
Sell
Analysts 12-Month Price Target:
Average 11.000
(-27.44% Downside)
Earnings
Latest Release
Jul 30, 2025
EPS / Forecast
-0.03 / -1.00
Revenue / Forecast
72.74M / 42.55M
People Also Watch
FAQ
What Stock Exchange Does Amarin Trade On?
Amarin is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Amarin?
The stock symbol for Amarin is "AMRN."
What Is the Amarin Market Cap?
As of today, Amarin market cap is 313.55M.
What Is Amarin's Earnings Per Share (TTM)?
The Amarin EPS (TTM) is -5.02.
From a Technical Analysis Perspective, Is AMRN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Amarin Stock Split?
Amarin has split 3 times.
How Many Employees Does Amarin Have?
Amarin has 275 employees.
What is the current trading status of Amarin (AMRN)?
As of 04 Aug 2025, Amarin (AMRN) is trading at a price of 15.16, with a previous close of 15.16. The stock has fluctuated within a day range of 14.05 to 15.65, while its 52-week range spans from 7.08 to 17.49.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.